Castle Biosciences, Inc. (CSTL)
38.08
-0.82
(-2.11%)
USD |
NASDAQ |
Jan 02, 13:16
Castle Biosciences EPS Diluted (Quarterly): -0.0172 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| Delcath Systems, Inc. | 0.0207 |
| Star Operating Cos., Inc. | 0.8643 |
| CorMedix, Inc. | 1.259 |
| CytoSorbents Corp. | -0.0505 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.501M |
| Revenue (Quarterly) | 83.04M |
| Total Expenses (Quarterly) | 83.54M |
| Enterprise Value | 885.04M |
| Gross Profit Margin (Quarterly) | 74.09% |
| Profit Margin (Quarterly) | -0.60% |
| Earnings Yield | -1.18% |
| Normalized Earnings Yield | -1.423 |